In phase III trials, medicines are tested on diverse patients—a patient population—in order to determine if their efficacy and safety can be confirmed also with a non-specific patient group. For this research, Sanofi required a multi-page label that provides product information in many different languages and firmly adheres to the plastic needle protection system without affecting the system’s functionality.
